Safety Data Sheet Sulfamethoxazole
according to Regulation (EC) No 1907/2006
1. Identification of the substance/preparation and of the company/undertaking
- pharmaceutical active substance: bacteriostatic, especially in
combination with trimethoprim (e.g. BACTRIM,trimethoprim:sulfamethoxazole 1:5)
F. Hoffmann-La Roche AGPostfachCH-4070 BaselSwitzerland
2. Hazards identification
- Very toxic to aquatic organisms, may cause long-term adverse
3. Composition/Information on ingredients
- N’-(5-Methyl-3-isoxazolyl)-sulfanilamide
- GANTANOL substance- 3-(4-Aminobenzenesulfonamide)-5-methylisoxazole- 4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide- 5-Methyl-3-sulfanilamido-isoxazole
Sulfamethoxazole 4. First-aid measures
- rinse immediately with tap water for 10 minutes - open eyelids
- remove contaminated clothes, wash affected skin with water and
5. Fire-fighting measures
- water spray jet, dry powder, foam, carbon dioxide
- consider dust explosion hazard- violent decomposition after exposure to heat- formation of toxic and corrosive combustion gases (nitrogen
- substance is hazardous for water: contain fire-fighting wastewater
6. Accidental release measures
- do not allow to enter drains or waterways- if the substance reaches waters or the sewer system, inform the
- collect solids (avoid dust formation) and hand over to waste
Sulfamethoxazole 7. Handling and storage Handling
- processing in closed systems, superposed by inert gas (e.g.
- protected from light- local exhaust ventilation necessary- take precautionary measures against electrostatic charging- avoid dust formation; very high dust explosion hazard
- stainless steel, aluminium, enamel, glass
- protected from heat and light- store under inert gas- keep container tightly closed
- tightly closing; material: stainless steel, glass, enamel, aluminium,
plywood, cardboard, plastic (polyethylene)
8. Exposure controls/Personal protection Engineering Measures Monitoring
- IOEL (Internal Occupational Exposure Limit): 1.0 mg/m3
- sampling on glass fibre filter and gravimetric or chemical
Personal protective equipment
- in case of open handling or accidental release:
particle mask or respirator with independent air supply
- protective gloves (neoprene, nitrile or butyl rubber)
Sulfamethoxazole 9. Physical and chemical properties
136 mg/l, water (37 °C)easily soluble, acetone (20 °C)slightly soluble, chloroform (20 °C)slightly soluble, ether (20 °C)
10. Stability and reactivity
- strong acids, oxidizing agents, atmospheric oxygen
- strongly exothermic decomposition at higher temperatures (>>
11. Toxicological information
- skin: non-irritant (rabbit)- eye: slightly irritating (rabbit)
- non-sensitizing (guinea pig)- may be sensitizing; (man, therapeutic use)
- not mutagenic (various in vivo and in vitro test systems)
- does not lower parental fertility (200 mg/kg/d, rat)- not teratogenic; (man, therapeutic doses)
- antibacterial chemotherapeutic, which, through folic acid
antagonism, inhibits the synthesis of proteins and nucleic acidsessential for cell division
- in human cells, therapeutic doses of sulfamethoxazole do not
significantly disturb folic acid metabolism
- therapeutic oral doses for monodrug use of sulfamethoxazol: 2g
- biological half-life: 10 hours; rapid and efficient resorption from the
Sulfamethoxazole
- rarely, systemic use may induce allergic skin reactions with
- other side effects: gastroinsteninal disturbances after oral uptake,
disorders of liver function; at high doses: urinary stones,disturbances of haematological parameters
12. Ecological information
0 %, 28 d(Closed Bottle Test, OECD No. 301 D)
0 %, 28 days(Zahn-Wellens test, OECD No. 302 B)
- rapid degradation, photodegradation (surface waters)
t1/2 10 h, summer, 50° Nt1/2 58 h, winter, 50° N(literature citation)
- highly toxic for algae (Selenastrum capricornutum)
EbC50 (72 h) 0.81 mg/lNOEbC (72 h) 0.22 mg/lErC50 (72 h) 3.4 mg/lNOErC (72 h) 0.45 mg/l(OECD No. 201)
- highly toxic for bluegreen algae (Synechococcus leopoliensis,
Cyanobacteria)EC50 (96 h) 0.0268 mg/lNOEC (96 h) 0.0059 mg/l(growth test)
- moderately toxic for planktonic crustaceans (Daphnia magna)
EC50 (48 h) 75 mg/lNOEC (48 h) 36 mg/l(OECD No. 202)
- barely inhibitory on aerobic bacterial reproduction (activated
sludge), no adverse influence on substrate biodegradation(activated sludge)NOEC 3.76 mg/l (highest concentration tested)(Closed Bottle Test, OECD No. 301 D)
- no adverse influence on substrate biodegradation (activated
sludge)concentration 3.8 mg/l(Closed Bottle Test, OECD No. 301 D)
13. Disposal considerations
- incinerate in qualified installation with flue gas scrubbing- observe local/national regulations regarding waste disposal
Sulfamethoxazole 14. Transport information
ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. 15. Regulatory information
Classification and labelling according to EU directives
Very toxic to aquatic organisms, may cause long-term adverseeffects in the aquatic environment.
This material and its container must be disposed of as hazardouswaste.
Avoid release to the environment. Refer to specialinstructions/Safety data sheets.
2: hazardous for water (own classification according to directiveVwVwS of 17.05.1999)
Sulfamethoxazole 16. Other information
- Additional safety investigations, e.g. from
Hazard Research Corporation (Denville, N.J. or Bundesamt für Materialprüfung (BAM, Berlin; dust explosion behaviour) are available from the safety laboratory.
- changes from previous version in sections 1, 2, 3, 6, 11, 16
The information in this safety data sheet is based on current scientific knowledge. It should not betaken as expressing or implying any warranty concerning product characteristics.
Q&A - termite protected plantation pine framing (H2-F Blue Pine) What is ‘termite protected’ plantation pine framing? Termite protected plantation pine framing has been treated with either a water-based or natural oil based solution containing long acting synthetic pyrethroid insecticides. These insecticides have been chosen for two reasons: 1. For their proven effectiveness in
Metabolic Assessment Form Name: ____________________________________________________ Age: ______ Sex: _____ Date: ______________ PART I Please list the 5 major health concerns in your order of importance: 1. _____________________________________________________________________________________________ 2. _____________________________________________________________________________